Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Treasury Shares (2016 - 2020)

Historic Treasury Shares for Neurocrine Biosciences (NBIX) over the last 10 years, with Q4 2020 value amounting to $1.5 million.

  • Neurocrine Biosciences' Treasury Shares rose 714.29% to $1.5 million in Q4 2020 from the same period last year, while for Dec 2020 it was $1.5 million, marking a year-over-year increase of 714.29%. This contributed to the annual value of $1.5 million for FY2020, which is 964.91% up from last year.
  • Latest data reveals that Neurocrine Biosciences reported Treasury Shares of $1.5 million as of Q4 2020, which was up 714.29% from $1.4 million recorded in Q4 2019.
  • Neurocrine Biosciences' Treasury Shares' 5-year high stood at $1.5 million during Q4 2020, with a 5-year trough of $200000.0 in Q2 2017.
  • For the 5-year period, Neurocrine Biosciences' Treasury Shares averaged around $642571.4, with its median value being $400000.0 (2016).
  • In the last 5 years, Neurocrine Biosciences' Treasury Shares tumbled by 5000.0% in 2017 and then surged by 5000.0% in 2018.
  • Over the past 5 years, Neurocrine Biosciences' Treasury Shares (Quarter) stood at $883000.0 in 2016, then rose by 22.31% to $1.1 million in 2017, then rose by 4.91% to $1.1 million in 2018, then grew by 23.57% to $1.4 million in 2019, then increased by 7.14% to $1.5 million in 2020.
  • Its last three reported values are $1.5 million in Q4 2020, $1.4 million for Q4 2019, and $1.1 million during Q4 2018.